Patty Murray Questions VA Secretary Collins on New Policies and EHR Issues

Congressional Engagement Policy

• 📌 Senator Patty Murray confronted VA Secretary Doug Collins regarding a new policy that limits congressional interaction with veterans on VA campuses.
• 🏛️ Murray stated this policy prevented her from hosting a veteran and provider round table, an activity she has done for over 30 years.
• 📝 She requested that the Secretary provide the newly written policy to all members of Congress, emphasizing it was not in writing when she was denied.
• 📜 Secretary Collins described the policy as an unwritten one that had been applied differently over the years, aiming to streamline coordination between offices.

Oversight and Bureaucracy

• 🔍 Murray expressed concern that a memo requiring the Chief of Staff to sign off on all congressional engagements would stonewall legitimate questions and create significant delays.
• 🗣️ Collins characterized the memo as a mischaracterization, intended to ensure coordination and streamline information flow for quicker responses.
• ⏳ Murray pushed back, arguing that routing all requests to the top would prevent timely responses and hinder oversight responsibilities.

EHR System and Staffing

• 🏥 Concerns were raised about the VA's decision to deploy a new Electronic Health Record (EHR) system at additional sites despite ongoing serious issues at existing locations.
• 📉 The potential impact of a reported plan to fire 80,000 employees on future EHR deployments was questioned.
• 🧑‍⚕️ Secretary Collins stated that employment reorganizations are separate from EHR deployments and do not involve frontline workers.

Clinical Trials and Research

• 🔬 Senator Murray highlighted the troubling decision not to renew terms for researchers working on critical clinical trials for veterans.
• ⚠️ She noted that planned trials have not started, ongoing trials have stopped, and others have fallen apart due to staff layoffs.
• ❓ A direct question was posed on whether the stopping of clinical trials would impact veteran care, to which Collins acknowledged the importance of clinical trials.
• ⏳ A 90-day pause was mentioned for examining clinical trials, with uncertainty about decisions after the pause ends.